This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Successfully funded
Capital at risk
overfunded
Iolight
127%
Raised
£319,750
Investors
333
Target
£250,000
Equity
15.45%
Pre-money valuation
£1,750,000

ioLight makes laboratory grade microscopes that fit in your pocket. Since a successful Crowdcube raise in 2015, the product launched in July 2016 with over 40 units already sold to customers including The Eden Project, Bayer and the University of Cambridge.

  • Targeting £100k revenue in 2017, with over £30k sold so far
  • Patent filed in March 2014
  • Over £400k funding received to date, including equity and awards
  • Combining optics with iPhones, images compare to lab equipment
Information In response to investor feedback, the company has increased the equity on offer with the valuation lowering from £2 million to £1.75 million. The pitch has been extended for two weeks and will now expire at midnight on the 24th March.

Idea

ioLight makes laboratory grade microscopes that fit in your pocket.

Good science relies on making primary measurements on samples in their environment. Yet for years scientists have had to collect samples in the field and take them back to a lab microscope for analysis. The ioLight microscope solves this problem capturing beautiful high-resolution images onto a tablet or phone anywhere. As well as improving the quality of science, it saves the cost and time of returning to site to collect better samples.

ioLight was incorporated in February 2014. Founders Andrew Monk and Richard Williams filed a patent application in March 2014. In 2015 the company raised a total of £400k in equity funding from a seed round and a Crowdcube round. The product was launched in July 2016 and sold over 30 units for £20k by the end of 2016.

Customers include The Eden Project; universities; schools, vets, pathologists and micro-engineering companies.

In an evaluation by the Quekett Microscopical Club, ioLight’s images were comparable with those from a lab microscope.

The Eden Project has bought ioLight microscopes and says they are “awesome”.

Cambridge University says “it produces high-quality images for rapid and high-resolution inspection of many samples, and is extremely convenient to use.”

Bayer Animal Health invited ioLight to exhibit on its stand at the London Vet Show.

THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE BY THE COMPANY RAISING FINANCE AS IDENTIFIED ABOVE (THE "COMPANY") IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY AND SUBJECT TO THESE TERMS AND CONDITIONS.  CROWDCUBE CAPITAL LTD IS AUTHORISED BY THE FCA AND CARRIES OUT DUE DILIGENCE ON EACH COMPANY THAT LISTS ON CROWDCUBE AS SET OUT HERE.
 
This investment opportunity is not an offer to the public and is only available to registered members of Crowdcube.com who have qualified and categorised themselves as able to invest.  The investment opportunity is not directed at persons located in the United States, Canada or Japan. Any person resident outside the United Kingdom who wishes to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict access.
In particular, unless otherwise determined by the Company and permitted by applicable law and regulation, it is not intended, subject to certain exceptions, that any offering of the securities mentioned in such materials (the "Securities") by the Company would be made, or any documentation be sent in or into, the United States, Canada or Japan.  There will be no public offering of the Securities in the United States.
 
In order to access the pitch you must first become a qualifying member of Crowdcube on the basis of your status as either (i) self-certified ‘high net worth investor’, (ii) certified ‘sophisticated investor’, (iii) self-certified as a ‘sophisticated investor’ or (iv) certified as a ‘restricted investor’, in each case in accordance with the FCA’s Conduct of Business Sourcebook Chapter 4.7.  Potential investors are encouraged to "cross examine" the Company by interactive due diligence and use of the available online forums to bring the "wisdom of the crowd" to bear.  Accessing the pitch also means you agree to Crowdcube’s most recent website terms and conditions and investor terms and conditions, which include Crowdcube's limitation of liability.
 
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.  Crowdcube’s or the Issuer’s press announcements and this information page do not constitute an offer to sell securities of the Company.  Further, it does not constitute a recommendation by the Company, Crowdcube or any other party to sell or buy securities in the Company.
 
By registering or logging into Crowdcube.com to view the investment opportunity, you certify that you are legally entitled to view the investment opportunities, are an authorised investor and you agree to all applicable terms and conditions on this website, including this disclaimer.

To see the rest of the Iolight pitch, join now.
It’s free, quick and easy.

Join

Already registered? Log in

To see the rest of the Iolight pitch, join now.
It’s free, quick and easy.

Iolight

Join to read more information about the Iolight team, documents, and what other investors are saying about the pitch.

If you choose to invest we won’t take your money until the pitch closes and you can cancel your investment at any time.

Crowdcube is a leading investment crowdfunding platform

Successfully Invested
£627m+
Registered Investors
720k+